Big Pharma

See the following -

Big Pharma Companies Open Up Cancer Trial Comparator Arm Data

Nick Paul Taylor | Fierce Biotech IT | April 11, 2014

A lot has changed in clinical trial transparency since Project Data Sphere outlined plans to share cancer results in 2012, with the European law voted in last week then still a distant threat. Even so, Pfizer ($PFE), Sanofi ($SNY) and the other groups behind the initiative think it still offers something different now that it has belatedly launched.

Read More »

Conshohocken-Based Non-Profit Aims to Revolutionize Biopharma

T. J. Sharpe | Philly.com | December 1, 2016

What if the next big thing in biopharma wasn’t produced by one of the big pharma companies that line the Northeast corridor between Philadelphia and New York City, but by a whole bunch of them?  Conshohocken-based TransCelerate BioPharma is attempting to accomplish this difficult feat by embracing cooperation instead of competition.  It is a 501(c)3 non-profit consortium of 18 pharmaceutical companies (and growing) that works with the FDA and global regulators to advance the industry through collaboration with researchers, industry organizations, and federal oversight agencies...

Read More »

Could There Be a Blockchain Solution to High Prescription Drug Prices?

Michael Scott | Bitcoin Magazine | March 28, 2017

Prescription drugs are one of the biggest contributors to soaring healthcare costs in the U.S.  And for both individuals and families, particularly where multiple prescriptions are needed, drug expenses can quickly escalate to thousands of dollars. According to a report from the Kaiser Family Foundation, 8 in 10 Americans would like the government to negotiate prices for those on Medicare. Additionally, Americans want limits set on the amount drug companies can charge for high-cost drugs, such as those to treat cancer...

Read More »

Culture as a Culprit of the Pharma R&D Crisis

Bruce Booth | Forbes | April 19, 2012

Fundamentally, I think the bulk of the last decade's productivity decline is attributable to a culture problem. The Big Pharma culture has been homogenized, purified, sterilized, whipped, stirred, filtered, etc and lost its ability to ferment the good stuff required to innovate. This isn't covered in most reviews of the productivity challenge facing our industry, because its nearly impossible to quantify, but it's well known and a huge issue.

Read More »

Doctors And Hospitals Got At Least $3.5 Billion From Industry In Just Five Months

Julia Belluz | Vox | September 30, 2014

...Lawsuits in recent years revealed that doctors' relationships with industry can alter their prescribing practices and decision-making for the worse, and pharmaceutical companies have paid out billions of dollars in fines for fraudulent marketing practices...

Read More »

Drug Bust: Generic Drug Prices On the Rise

Jeremy A. Greene | Slate | November 20, 2014

For 30 years, generic medications helped make health care cheaper. Why is their cost surging?...

Read More »

Fidgeting May (or May Not) Be Good For You

I swore I wasn't going to write about fidget spinners.  Just a toy, just be the latest fad -- the Rubik's cube of this generation, or perhaps the Pokémon Go of this year -- with no broader implications, for health care or anything else.  Yet here I am, writing about them after all. If you know any children, you already know what a fidget spinner is.  You may even have one yourself.  They seem to be everywhere lately, even in the hands of President Trump's youngest son as he exited Marine One recently. What that says about us is not quite clear...

How Big Pharma Gets Away With Selling Crystal Meth To Children: By Renaming It ‘Adderall’

Staff Writer | Healthy Life and Fitness | February 19, 2016

In a recent appearance on All In with Chris Hayes on MSNBC, drug abuse and addiction expert Carl Hart of Columbia University made a shocking claim: There isn’t much difference between the demonized street drug methamphetamine (also known as meth or crystal meth) and the prescription drug Adderall...

Read More »

How to Make Doctors Irrelevant

Daniela Drake | The Daily Beast | April 23, 2014

After a simple, modified Paleo diet reversed her multiple sclerosis, one doctor is exposing health care and big pharma’s dirty secret: Prescriptions don’t make you well. Read More »

Inside Big Pharma's Fight to Block Recreational Marijuana

Alfonso Serrano | The Guardian | October 10, 2016

Marijuana legalization will unleash misery on Arizona, according to a wave of television ads that started rolling out across the state last month. Replete with ominous music, the advertisements feature lawmakers and teachers who paint a bleak future for Arizona’s children if voters approve Proposition 205, a measure that would allow people aged 21 and over to possess an ounce of pot and grow up to six plants for recreational use. “Colorado schools were promised millions in new revenues” when the state approved recreational pot use, says the voiceover in one ad. Instead, schoolchildren were plagued by “marijuana edibles that look like candy”...

Read More »

Is Big Pharma Cooking Up the Current Drug Shortage?

Rom Shinkman | Fierce Health Finance | October 4, 2011

Many hospital finance executives have had that sudden and unpleasant expense pop up on their monthly expense spreadsheet as of late: The normally cheap generic injectable or oral medication suddenly costing 20 or 50 times the normal price--if it can be had at all. Read More »

Is the American Heart Association a Terrorist Organization?

Kevin Michael Geary | Medium | June 21, 2017

A few days ago, the AHA stole the attention of headlines across the globe with a report that sounded like it was straight out of the 1990s: Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. In this report, the AHA doubled down on their attacks against coconut oil and saturated fat. Frank Sacks, lead author on the report, reportedly said that he has no idea why people think coconut oil is healthy...

Read More »

Low-Carb on Trial (Galileo Had It Easy)

Nora Gedgaudas | Primal Body Primal Mind | November 14, 2016

A recent exposé in the New York Times[1] revealed massive and pervasive fraud and collusion between the sugar industry and certain medical authorities in the 1960’s designed to erroneously promote saturated fat as the culprit behind heart disease. Effectively diverting attention from the real source of the problem (the increasing consumption of dietary sugar), the food industry conspired with key authorities within the medical establishment to serve their own best interests at the expense of public health.  Historic documents showed that they were intentionally concealing the fact that sugar, instead of fat, was knowingly to blame...

Read More »

Open Access in Europe to Big Pharma clinical trial data

Andrew Jack | Financial Times | April 4, 2013

When Guido Rasi took charge of Europe’s medicines’ regulator in 2011 he inherited an explosive dossier that is now poised to transform drug development. Read More »

Pharma, Data Veteran Stephen Friend Bites At Apple’s Health Offer

Alex Lash | Xconomy | June 23, 2016

Consumer tech giant Apple, which has spent considerable effort positioning its products as health and fitness helpers, has just hired someone who knows Big Pharma and Big Data. Stephen Friend, a veteran of drug R&D and, more recently, a nonprofit effort to foster more collaborative biomedical research and more data sharing, is joining Apple in an unspecified capacity. The news emerged today from Sage Bionetworks, the Seattle nonprofit that Friend founded after leaving drug giant Merck, where he was a senior research executive for eight years...

Read More »